CME Group Inc.
BG ˙ BUL ˙ US12572Q1058
SecurityBG:MX4A / CME Group Inc.
InstitutionPenserra Capital Management LLC
Latest Disclosed Ownership2,081 shares
Latest Disclosed Value $ 613
Penserra Capital Management LLC reports 3.58% increase in ownership of MX4A / CME Group Inc.

On May 11, 2026 - Penserra Capital Management LLC filed a 13F-HR form disclosing ownership of 2,081 shares of CME Group Inc. (BG:MX4A) valued at $613 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 2,009 shares of CME Group Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F CME GROUP COM 12572Q105 2,081 72 3.58 1 0.0072
2026-02-12 2025-12-31 13F CME GROUP COM 12572Q105 2,009 41 2.08 1 0.0065
2025-11-04 2025-09-30 13F CME GROUP COM 12572Q105 1,968 22 1.13 1 0.0064
2025-08-06 2025-06-30 13F CME GROUP COM 12572Q105 1,946 -3,397 -63.58 1 -100.00 0.0075
2025-04-29 2025-03-31 13F CME GROUP COM 12572Q105 5,343 2,776 108.14 1 0.0252
2025-02-13 2024-12-31 13F CME GROUP COM 12572Q105 2,567 880 52.16 1 0.0109
2024-11-12 2024-09-30 13F CME GROUP COM 12572Q105 1,687 -478,575 -99.65 0 -100.00 0.0081
2024-08-13 2024-06-30 13F CME GROUP COM 12572Q105 480,262 -14,339 -2.90 94 -11.32 1.1952
2024-05-15 2024-03-31 13F CME GROUP COM 12572Q105 494,601 72,094 17.06 106 20.45 1.3371
2024-02-14 2023-12-31 13F CME GROUP COM 12572Q105 422,507 418,617 10,761.36 89 1.6726
2023-11-15 2023-09-30 13F CME GROUP COM 12572Q105 3,890 -227 -5.51 1 0.0161
2023-08-11 2023-06-30 13F CME GROUP COM 12572Q105 4,117 2,247 120.16 1 0.0151
2023-04-24 2023-03-31 13F CME GROUP COM 12572Q105 1,870 -17,070 -90.13 0 -100.00 0.0074
2023-02-13 2022-12-31 13F CME GROUP COM 12572Q105 18,940 17,215 997.97 3 -99.02 0.0699
2022-11-14 2022-09-30 13F CME GROUP COM 12572Q105 1,725 44 2.62 305 -11.34 0.0086
2022-08-15 2022-06-30 13F CME GROUP COM 12572Q105 1,681 -1 -0.06 344 -14.00 0.0094
2022-05-13 2022-03-31 13F CME GROUP COM 12572Q105 1,682 -53 -3.05 400 1.27 0.0095
2022-02-15 2021-12-31 13F CME GROUP COM 12572Q105 1,735 280 19.24 395 41.07 0.0084
2021-11-15 2021-09-30 13F CME GROUP COM 12572Q105 1,455 160 12.36 280 2.19 0.0058
2021-08-12 2021-06-30 13F CME GROUP COM 12572Q105 1,295 394 43.73 274 48.91 0.0050
2021-05-13 2021-03-31 13F CME GROUP COM 12572Q105 901 150 19.97 184 35.29 0.0034
2021-02-12 2020-12-31 13F CME GROUP COM 12572Q105 751 -1,899 -71.66 136 -69.23 0.0032
2020-11-13 2020-09-30 13F CME GROUP COM 12572Q105 2,650 568 27.28 442 31.16 0.0168
2020-08-14 2020-06-30 13F CME GROUP COM 12572Q105 2,082 162 8.44 337 -1.46 0.0174
2020-05-14 2020-03-31 13F CME GROUP COM 12572Q105 1,920 142 7.99 342 -3.66 0.0233
2020-02-14 2019-12-31 13F CME GROUP COM 12572Q105 1,778 -6,124 -77.50 355 -78.72 0.0229
2019-11-15 2019-09-30 13F CME GROUP COM 12572Q105 7,902 -2,245 -22.12 1,668 -15.24 0.1416
2019-08-13 2019-06-30 13F CME GROUP COM 12572Q105 10,147 -1,594 -13.58 1,968 -6.20 0.1531
2019-05-08 2019-03-31 13F CME GROUP COM CL A 12572Q105 11,741 -274 -2.28 2,098 -7.13 0.1680
2019-02-06 2018-12-31 13F CME GROUP COM CL A 12572Q105 12,015 -4,049 -25.21 2,259 -17.34 0.2194
2018-11-05 2018-09-30 13F CME GROUP COM CL A 12572Q105 16,064 10,598 193.89 2,733 476.58 0.1678
2018-08-13 2018-06-30 13F CME GROUP INC COM CL A 12572Q105 5,466 4,293 365.98 474 150.79 0.0299
2018-05-08 2018-03-31 13F CME GROUP COM CL A 12572Q105 1,173 -2,911 -71.28 189 -68.29 0.0179
2018-02-07 2017-12-31 13F CME GROUP COM CL A 12572Q105 4,084 3,766 1,184.28 596 1,286.05 0.0784
2017-10-26 2017-09-30 13F CME GROUP COM CL A 12572Q105 318 42 15.22 43 26.47 0.0102
2017-08-21 2017-06-30 13F/A-2 CME GROUP COM 12572Q105 276 276 0.00 34 0.00 0.0123
2017-08-21 2017-06-30 13F/A-1 CME GROUP COM 12572Q105 276 0 34 0.0140
2017-08-07 2017-06-30 13F CME GROUP COM 12572Q105 276 276 34
2017-05-09 2017-03-31 13F CME GROUP COM 12572Q105 0 -231 -100.00 0 -100.00
2017-02-10 2016-12-31 13F CME GROUP COM 12572Q105 231 51 28.33 26 44.44 0.0030
2016-11-03 2016-09-30 13F CME GROUP COM 12572Q105 180 72 66.67 18 63.64 0.0022
2016-08-09 2016-06-30 13F CME GROUP COM 12572Q105 108 42 63.64 11 83.33 0.0016
2016-05-10 2016-03-31 13F CME GROUP COM 12572Q105 66 -8 -10.81 6 -14.29 0.0006
2016-02-08 2015-12-31 13F * CME GROUP INC COM COM 12572Q105 74 74 7 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.